Cargando…

5-HT(1A )gene promoter polymorphism and [(18)F]MPPF binding potential in healthy subjects: a PET study

BACKGROUND: Previous Positron Emission Tomography (PET) studies of 5-HT(1A )receptors have shown an influence of several genetic factors, including the triallelic serotonin transporter gene-linked polymorphic region on the binding potential (BP(ND)) of these receptors. The aim of our study was to in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lothe, Amélie, Boni, Claudette, Costes, Nicolas, Bouvard, Sandrine, Gorwood, Philip, Lavenne, Franck, Alvarez, Marion, Ryvlin, Philippe
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909987/
https://www.ncbi.nlm.nih.gov/pubmed/20609217
http://dx.doi.org/10.1186/1744-9081-6-37
_version_ 1782184343150526464
author Lothe, Amélie
Boni, Claudette
Costes, Nicolas
Bouvard, Sandrine
Gorwood, Philip
Lavenne, Franck
Alvarez, Marion
Ryvlin, Philippe
author_facet Lothe, Amélie
Boni, Claudette
Costes, Nicolas
Bouvard, Sandrine
Gorwood, Philip
Lavenne, Franck
Alvarez, Marion
Ryvlin, Philippe
author_sort Lothe, Amélie
collection PubMed
description BACKGROUND: Previous Positron Emission Tomography (PET) studies of 5-HT(1A )receptors have shown an influence of several genetic factors, including the triallelic serotonin transporter gene-linked polymorphic region on the binding potential (BP(ND)) of these receptors. The aim of our study was to investigate the relationship between a 5-HT(1A )promoter polymorphism and the binding potential of another selective 5-HT(1A )receptor antagonist, [(18)F]MPPF, in healthy subjects. METHODS: Thirty-five volunteers, including 23 women, underwent an [(18)F]MPPF scan and were genotyped for both the C(-1019)G 5-HT(1A )promoter polymorphism and the triallelic serotonin transporter gene-linked polymorphic region. We used a simplified reference tissue model to generate parametric images of BP(ND). Whole brain Statistical Parametric Mapping and raphe nuclei region of interest analyses were performed to look for an association of [(18)F]MPPF BP(ND )with the C(-1019)G 5-HT(1A )promoter polymorphism. RESULTS: Among the 35 subjects, 5-HT(1A )promoter genotypes occurred with the following frequencies: three G/G, twenty-one G/C, and eleven C/C. No difference of [(18)F]MPPF BP(ND )between groups was observed, except for two women who were homozygote carriers for the G allele and showed greater binding potential compared to other age-matched women over the frontal and temporal neocortex. However, the biological relevance of this result remains uncertain due to the very small number of subjects with a G/G genotype. These findings were not modified by excluding individuals carrying the S/S genotype of the serotonin transporter gene-linked polymorphic region. CONCLUSIONS: We failed to observe an association between the C(-1019)G 5-HT(1A )promoter polymorphism and [(18)F]MPPF binding in healthy subjects. However our data suggest that the small number of women homozygote for the G allele might have greater [(18)F]MPPF BP(ND )relative to other individuals. This finding should be confirmed in a larger sample.
format Text
id pubmed-2909987
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29099872010-07-27 5-HT(1A )gene promoter polymorphism and [(18)F]MPPF binding potential in healthy subjects: a PET study Lothe, Amélie Boni, Claudette Costes, Nicolas Bouvard, Sandrine Gorwood, Philip Lavenne, Franck Alvarez, Marion Ryvlin, Philippe Behav Brain Funct Research BACKGROUND: Previous Positron Emission Tomography (PET) studies of 5-HT(1A )receptors have shown an influence of several genetic factors, including the triallelic serotonin transporter gene-linked polymorphic region on the binding potential (BP(ND)) of these receptors. The aim of our study was to investigate the relationship between a 5-HT(1A )promoter polymorphism and the binding potential of another selective 5-HT(1A )receptor antagonist, [(18)F]MPPF, in healthy subjects. METHODS: Thirty-five volunteers, including 23 women, underwent an [(18)F]MPPF scan and were genotyped for both the C(-1019)G 5-HT(1A )promoter polymorphism and the triallelic serotonin transporter gene-linked polymorphic region. We used a simplified reference tissue model to generate parametric images of BP(ND). Whole brain Statistical Parametric Mapping and raphe nuclei region of interest analyses were performed to look for an association of [(18)F]MPPF BP(ND )with the C(-1019)G 5-HT(1A )promoter polymorphism. RESULTS: Among the 35 subjects, 5-HT(1A )promoter genotypes occurred with the following frequencies: three G/G, twenty-one G/C, and eleven C/C. No difference of [(18)F]MPPF BP(ND )between groups was observed, except for two women who were homozygote carriers for the G allele and showed greater binding potential compared to other age-matched women over the frontal and temporal neocortex. However, the biological relevance of this result remains uncertain due to the very small number of subjects with a G/G genotype. These findings were not modified by excluding individuals carrying the S/S genotype of the serotonin transporter gene-linked polymorphic region. CONCLUSIONS: We failed to observe an association between the C(-1019)G 5-HT(1A )promoter polymorphism and [(18)F]MPPF binding in healthy subjects. However our data suggest that the small number of women homozygote for the G allele might have greater [(18)F]MPPF BP(ND )relative to other individuals. This finding should be confirmed in a larger sample. BioMed Central 2010-07-07 /pmc/articles/PMC2909987/ /pubmed/20609217 http://dx.doi.org/10.1186/1744-9081-6-37 Text en Copyright ©2010 Lothe et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Lothe, Amélie
Boni, Claudette
Costes, Nicolas
Bouvard, Sandrine
Gorwood, Philip
Lavenne, Franck
Alvarez, Marion
Ryvlin, Philippe
5-HT(1A )gene promoter polymorphism and [(18)F]MPPF binding potential in healthy subjects: a PET study
title 5-HT(1A )gene promoter polymorphism and [(18)F]MPPF binding potential in healthy subjects: a PET study
title_full 5-HT(1A )gene promoter polymorphism and [(18)F]MPPF binding potential in healthy subjects: a PET study
title_fullStr 5-HT(1A )gene promoter polymorphism and [(18)F]MPPF binding potential in healthy subjects: a PET study
title_full_unstemmed 5-HT(1A )gene promoter polymorphism and [(18)F]MPPF binding potential in healthy subjects: a PET study
title_short 5-HT(1A )gene promoter polymorphism and [(18)F]MPPF binding potential in healthy subjects: a PET study
title_sort 5-ht(1a )gene promoter polymorphism and [(18)f]mppf binding potential in healthy subjects: a pet study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909987/
https://www.ncbi.nlm.nih.gov/pubmed/20609217
http://dx.doi.org/10.1186/1744-9081-6-37
work_keys_str_mv AT lotheamelie 5ht1agenepromoterpolymorphismand18fmppfbindingpotentialinhealthysubjectsapetstudy
AT boniclaudette 5ht1agenepromoterpolymorphismand18fmppfbindingpotentialinhealthysubjectsapetstudy
AT costesnicolas 5ht1agenepromoterpolymorphismand18fmppfbindingpotentialinhealthysubjectsapetstudy
AT bouvardsandrine 5ht1agenepromoterpolymorphismand18fmppfbindingpotentialinhealthysubjectsapetstudy
AT gorwoodphilip 5ht1agenepromoterpolymorphismand18fmppfbindingpotentialinhealthysubjectsapetstudy
AT lavennefranck 5ht1agenepromoterpolymorphismand18fmppfbindingpotentialinhealthysubjectsapetstudy
AT alvarezmarion 5ht1agenepromoterpolymorphismand18fmppfbindingpotentialinhealthysubjectsapetstudy
AT ryvlinphilippe 5ht1agenepromoterpolymorphismand18fmppfbindingpotentialinhealthysubjectsapetstudy